FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Cosendai Gregoire
   2. Issuer Name and Ticker or Trading Symbol
SECOND SIGHT MEDICAL PRODUCTS INC [EYES] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
VP Clinical Affairs
(Last)
(First)
(Middle)
12744 SAN FERNANDO ROAD, SUITE 400		 3. Date of Earliest Transaction (Month/Day/Year)
01/04/2018
(Street)

SYLMAR, CA 91342		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock               23,484 (1) D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $ 2.06 01/04/2018   A   65,000   01/04/2019(2) 01/04/2028 Common Stock 65,000 (6) 65,000 D  
Warrant to Purchase Common Stock $ 1.47             03/14/2017 03/14/2022 Common Stock 3,366   3,366 D  
Non-Qualified Stock Option (right to buy) $ 1.97             01/03/2018(3) 01/03/2027 Common Stock 228,190   228,190 D  
Non-Qualified Stock Option (right to buy) $ 4.10             01/21/2017(3) 01/21/2026 Common Stock 11,513   11,513 D  
Non-Qualified Stock Option (right to buy) $ 5             11/01/2009(4) 11/01/2018 Common Stock 20,000   200,000 D  
Non-Qualified Stock Option (right to buy) $ 5             02/01/2010(4) 02/01/2019 Common Stock 5,081   5,081 D  
Non-Qualified Stock Option (right to buy) $ 5             05/01/2010(4) 05/01/2019 Common Stock 10,000   10,000 D  
Non-Qualified Stock Option (right to buy) $ 5             02/01/2011(4) 02/01/2020 Common Stock 14,475   14,475 D  
Non-Qualified Stock Option (right to buy) $ 5             06/01/2011(4) 06/01/2020 Common Stock 2,125   2,125 D  
Non-Qualified Stock Option (right to buy) $ 5             12/01/2011(5) 12/01/2020 Common Stock 25,000   25,000 D  
Non-Qualified Stock Option (right to buy) $ 5             03/01/2012(5) 03/01/2021 Common Stock 6,650   6,650 D  
Non-Qualified Stock Option (right to buy) $ 5             03/01/2013(5) 03/01/2022 Common Stock 7,750   7,750 D  
Non-Qualified Stock Option (right to buy) $ 5             04/01/2015(5) 04/01/2024 Common Stock 10,937   10,937 D  
Non-Qualified Stock Option (right to buy) $ 9             09/26/2015(5) 09/26/2024 Common Stock 51,009   51,009 D  
Non-Qualified Stock Option (right to buy) $ 13.09             03/26/2016(5) 03/25/2025 Common Stock 6,250   6,250 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Cosendai Gregoire
12744 SAN FERNANDO ROAD
SUITE 400
SYLMAR, CA 91342		       VP Clinical Affairs  

Signatures

 Gregoire Cosendai   01/08/2018
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Shares acquired as part of scheduled ESPP purchases.
(2) The shares subject to this option shall vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of January 4, 2018 (the "Vesting Commencement Date") and 6.25% of the total number of shares shall vest each quarterly anniversary of the Vesting Commencement Date thereafter, for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.
(3) Options vest over a four year term of which one-fourth vest on the Date Exercisable, with the remaining options vesting quarterly over three years thereafter.
(4) Options vest in 5 yearly increments starting with the Date Exercisable
(5) Options vest in 4 yearly increments starting with the Date Exercisable
(6) Not Applicable

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.